WADA The 2017 Monitoring Program*
The following substances are placed on the 2017 Monitoring Program:
1.) Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and synephrine.
2.) Narcotics: In-Competition only: Codeine, mitragynine and tramadol.
3.) Glucocorticoids: In-Competition (by routes of administration other than oral, intravenous, intramuscular or rectal) and Out-of-Competition
(all routes of administration).
4.) Telmisartan: In- and Out-of-Competition.
5.) Beta-2-agonists: In- and Out-of-Competition: any combination of beta-2-agonists.
* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”
